nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGDR2—female reproductive system—rectum cancer	0.0311	0.0666	CbGeAlD
Sulindac—AKR1B1—seminal vesicle—rectum cancer	0.0256	0.0549	CbGeAlD
Sulindac—AKR1B1—epithelium—rectum cancer	0.0223	0.0477	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—rectum cancer	0.0215	0.0459	CbGeAlD
Sulindac—AKR1B1—renal system—rectum cancer	0.0207	0.0442	CbGeAlD
Sulindac—AKR1B1—urethra—rectum cancer	0.0203	0.0434	CbGeAlD
Sulindac—AKR1B1—mammalian vulva—rectum cancer	0.0193	0.0413	CbGeAlD
Sulindac—MAPK3—seminal vesicle—rectum cancer	0.0186	0.0398	CbGeAlD
Sulindac—AKR1B1—female reproductive system—rectum cancer	0.0165	0.0354	CbGeAlD
Sulindac—MAPK3—epithelium—rectum cancer	0.0161	0.0345	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—rectum cancer	0.0156	0.0333	CbGeAlD
Sulindac—PPARD—mammalian vulva—rectum cancer	0.0152	0.0325	CbGeAlD
Sulindac—MAPK3—renal system—rectum cancer	0.015	0.032	CbGeAlD
Sulindac—AKR1B1—vagina—rectum cancer	0.015	0.032	CbGeAlD
Sulindac—MAPK3—urethra—rectum cancer	0.0147	0.0315	CbGeAlD
Sulindac—MAPK3—mammalian vulva—rectum cancer	0.014	0.03	CbGeAlD
Sulindac—PPARD—female reproductive system—rectum cancer	0.013	0.0278	CbGeAlD
Sulindac—MAPK3—female reproductive system—rectum cancer	0.012	0.0257	CbGeAlD
Sulindac—PPARD—vagina—rectum cancer	0.0118	0.0252	CbGeAlD
Sulindac—MAPK3—vagina—rectum cancer	0.0108	0.0232	CbGeAlD
Sulindac—AKR1B1—lymph node—rectum cancer	0.00968	0.0207	CbGeAlD
Sulindac—PPARD—lymph node—rectum cancer	0.00761	0.0163	CbGeAlD
Sulindac—MAPK3—lymph node—rectum cancer	0.00702	0.015	CbGeAlD
Sulindac—PTGS1—seminal vesicle—rectum cancer	0.00505	0.0108	CbGeAlD
Sulindac—CYP1A1—epithelium—rectum cancer	0.005	0.0107	CbGeAlD
Sulindac—PTGS2—seminal vesicle—rectum cancer	0.00483	0.0103	CbGeAlD
Sulindac—CYP1A2—renal system—rectum cancer	0.0047	0.01	CbGeAlD
Sulindac—CYP1A1—renal system—rectum cancer	0.00463	0.00991	CbGeAlD
Sulindac—CYP1A1—urethra—rectum cancer	0.00455	0.00974	CbGeAlD
Sulindac—PTGS1—epithelium—rectum cancer	0.00439	0.00939	CbGeAlD
Sulindac—CYP1A1—mammalian vulva—rectum cancer	0.00433	0.00927	CbGeAlD
Sulindac—PTGS1—smooth muscle tissue—rectum cancer	0.00423	0.00905	CbGeAlD
Sulindac—PTGS2—epithelium—rectum cancer	0.00419	0.00897	CbGeAlD
Sulindac—PTGS1—renal system—rectum cancer	0.00407	0.00871	CbGeAlD
Sulindac—PTGS2—smooth muscle tissue—rectum cancer	0.00404	0.00865	CbGeAlD
Sulindac—PTGS2—renal system—rectum cancer	0.00389	0.00832	CbGeAlD
Sulindac—PTGS2—urethra—rectum cancer	0.00382	0.00818	CbGeAlD
Sulindac—PTGS1—mammalian vulva—rectum cancer	0.00381	0.00814	CbGeAlD
Sulindac—CYP1A1—female reproductive system—rectum cancer	0.00371	0.00794	CbGeAlD
Sulindac—CYP1A1—vagina—rectum cancer	0.00336	0.00718	CbGeAlD
Sulindac—ALB—lymph node—rectum cancer	0.00335	0.00716	CbGeAlD
Sulindac—PTGS1—female reproductive system—rectum cancer	0.00326	0.00697	CbGeAlD
Sulindac—PTGS2—female reproductive system—rectum cancer	0.00312	0.00667	CbGeAlD
Sulindac—PTGS1—vagina—rectum cancer	0.00295	0.00631	CbGeAlD
Sulindac—PTGS2—vagina—rectum cancer	0.00282	0.00603	CbGeAlD
Sulindac—CYP1A1—lymph node—rectum cancer	0.00217	0.00464	CbGeAlD
Sulindac—MAPK3—Signalling to ERKs—NRAS—rectum cancer	0.00215	0.00403	CbGpPWpGaD
Sulindac—MAPK3—GRB2 events in ERBB2 signaling—HRAS—rectum cancer	0.00213	0.004	CbGpPWpGaD
Sulindac—MAPK3—GMCSF-mediated signaling events—KRAS—rectum cancer	0.00212	0.00398	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0021	0.00394	CbGpPWpGaD
Sulindac—MAPK3—Nongenotropic Androgen signaling—HRAS—rectum cancer	0.00208	0.0039	CbGpPWpGaD
Sulindac—MAPK3—CXCR3-mediated signaling events—KRAS—rectum cancer	0.00208	0.0039	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00205	0.00385	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—NRAS—rectum cancer	0.00204	0.00382	CbGpPWpGaD
Sulindac—MAPK3—EPHB forward signaling—KRAS—rectum cancer	0.00203	0.00382	CbGpPWpGaD
Sulindac—MAPK3—SHC1 events in ERBB2 signaling—HRAS—rectum cancer	0.00203	0.0038	CbGpPWpGaD
Sulindac—MAPK3—IL-5 Signaling Pathway—KRAS—rectum cancer	0.00199	0.00374	CbGpPWpGaD
Sulindac—MAPK3—Alpha 6 Beta 4 signaling pathway—HRAS—rectum cancer	0.00198	0.00371	CbGpPWpGaD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—KRAS—rectum cancer	0.00195	0.00367	CbGpPWpGaD
Sulindac—MAPK3—Signalling to RAS—HRAS—rectum cancer	0.00193	0.00362	CbGpPWpGaD
Sulindac—MAPK3—Trk receptor signaling mediated by the MAPK pathway—HRAS—rectum cancer	0.00193	0.00362	CbGpPWpGaD
Sulindac—MAPK3—VEGFR2 mediated cell proliferation—HRAS—rectum cancer	0.00193	0.00362	CbGpPWpGaD
Sulindac—MAPK3—Signaling of Hepatocyte Growth Factor Receptor—HRAS—rectum cancer	0.00193	0.00362	CbGpPWpGaD
Sulindac—PTGS1—lymph node—rectum cancer	0.00191	0.00408	CbGeAlD
Sulindac—MAPK3—FCERI mediated MAPK activation—KRAS—rectum cancer	0.00188	0.00353	CbGpPWpGaD
Sulindac—MAPK3—FRS2-mediated cascade—KRAS—rectum cancer	0.00185	0.00347	CbGpPWpGaD
Sulindac—MAPK3—Signalling to ERKs—KRAS—rectum cancer	0.00185	0.00347	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-2-mediated signaling events—HRAS—rectum cancer	0.00184	0.00346	CbGpPWpGaD
Sulindac—PTGS2—lymph node—rectum cancer	0.00182	0.0039	CbGeAlD
Sulindac—MAPK3—IL2-mediated signaling events—NRAS—rectum cancer	0.00182	0.00342	CbGpPWpGaD
Sulindac—MAPK3—GMCSF-mediated signaling events—HRAS—rectum cancer	0.0018	0.00339	CbGpPWpGaD
Sulindac—MAPK3—CXCR3-mediated signaling events—HRAS—rectum cancer	0.00177	0.00331	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—KRAS—rectum cancer	0.00175	0.00329	CbGpPWpGaD
Sulindac—MAPK3—EPHB forward signaling—HRAS—rectum cancer	0.00173	0.00325	CbGpPWpGaD
Sulindac—MAPK3—Signaling events regulated by Ret tyrosine kinase—HRAS—rectum cancer	0.00173	0.00325	CbGpPWpGaD
Sulindac—MAPK3—PDGF Pathway—HRAS—rectum cancer	0.00173	0.00325	CbGpPWpGaD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—HRAS—rectum cancer	0.00166	0.00312	CbGpPWpGaD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—NRAS—rectum cancer	0.00165	0.0031	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—rectum cancer	0.00164	0.00308	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—HRAS—rectum cancer	0.00163	0.00306	CbGpPWpGaD
Sulindac—MAPK3—FCERI mediated MAPK activation—HRAS—rectum cancer	0.0016	0.003	CbGpPWpGaD
Sulindac—MAPK3—Signalling to ERKs—HRAS—rectum cancer	0.00157	0.00295	CbGpPWpGaD
Sulindac—MAPK3—FRS2-mediated cascade—HRAS—rectum cancer	0.00157	0.00295	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—HRAS—rectum cancer	0.00157	0.00295	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—KRAS—rectum cancer	0.00157	0.00294	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—NRAS—rectum cancer	0.00155	0.00291	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—NRAS—rectum cancer	0.00155	0.00291	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—ITGA2—rectum cancer	0.00155	0.0029	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—TYMS—rectum cancer	0.00154	0.00289	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	0.00153	0.00288	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00153	0.00287	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—NRAS—rectum cancer	0.00151	0.00284	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—HRAS—rectum cancer	0.00149	0.0028	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—HRAS—rectum cancer	0.00144	0.0027	CbGpPWpGaD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—KRAS—rectum cancer	0.00142	0.00267	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—rectum cancer	0.00139	0.00262	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—KRAS—rectum cancer	0.00135	0.00254	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—KRAS—rectum cancer	0.00134	0.00251	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—KRAS—rectum cancer	0.00134	0.00251	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—HRAS—rectum cancer	0.00133	0.0025	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—HRAS—rectum cancer	0.00133	0.0025	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	0.00132	0.00248	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—NRAS—rectum cancer	0.0013	0.00245	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—KRAS—rectum cancer	0.0013	0.00245	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—NRAS—rectum cancer	0.00127	0.00238	CbGpPWpGaD
Sulindac—MAPK3—Kit receptor signaling pathway—HRAS—rectum cancer	0.00124	0.00233	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—NRAS—rectum cancer	0.00123	0.00231	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00123	0.00231	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—NRAS—rectum cancer	0.00122	0.00229	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	0.00121	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—HRAS—rectum cancer	0.00121	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—rectum cancer	0.0012	0.00226	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—NRAS—rectum cancer	0.00119	0.00223	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—NRAS—rectum cancer	0.00119	0.00223	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—NRAS—rectum cancer	0.00119	0.00223	CbGpPWpGaD
Sulindac—MAPK3—Endothelins—HRAS—rectum cancer	0.00118	0.00221	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	0.00117	0.0022	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	0.00117	0.0022	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—HRAS—rectum cancer	0.00115	0.00216	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—HRAS—rectum cancer	0.00113	0.00213	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—HRAS—rectum cancer	0.00113	0.00213	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—HRAS—rectum cancer	0.00113	0.00213	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—KRAS—rectum cancer	0.00112	0.00211	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	0.00112	0.00211	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—HRAS—rectum cancer	0.00112	0.00211	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—HRAS—rectum cancer	0.00111	0.00208	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ITGA2—rectum cancer	0.0011	0.00207	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00109	0.00205	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—KRAS—rectum cancer	0.00109	0.00205	CbGpPWpGaD
Sulindac—MAPK3—CDC42 signaling events—HRAS—rectum cancer	0.00108	0.00203	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ITGA2—rectum cancer	0.00108	0.00203	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—NRAS—rectum cancer	0.00107	0.00201	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00107	0.002	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—KRAS—rectum cancer	0.00106	0.00199	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.00106	0.00199	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—NRAS—rectum cancer	0.00105	0.00198	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—KRAS—rectum cancer	0.00105	0.00197	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—NRAS—rectum cancer	0.00105	0.00196	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—rectum cancer	0.00103	0.00193	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—HRAS—rectum cancer	0.00102	0.00192	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—KRAS—rectum cancer	0.00102	0.00192	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—KRAS—rectum cancer	0.00102	0.00192	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—KRAS—rectum cancer	0.00102	0.00192	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—rectum cancer	0.000998	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.000998	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—NRAS—rectum cancer	0.000995	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—NRAS—rectum cancer	0.000988	0.00186	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—rectum cancer	0.000973	0.00183	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—HRAS—rectum cancer	0.000954	0.00179	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.000941	0.00177	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—NRAS—rectum cancer	0.000931	0.00175	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—HRAS—rectum cancer	0.000927	0.00174	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—KRAS—rectum cancer	0.000921	0.00173	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—rectum cancer	0.000918	0.00172	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000909	0.00171	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—KRAS—rectum cancer	0.000907	0.0017	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—HRAS—rectum cancer	0.000902	0.00169	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.000901	0.00169	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—KRAS—rectum cancer	0.0009	0.00169	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—HRAS—rectum cancer	0.000893	0.00168	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—HRAS—rectum cancer	0.000886	0.00166	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—HRAS—rectum cancer	0.00087	0.00163	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—HRAS—rectum cancer	0.00087	0.00163	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—HRAS—rectum cancer	0.00087	0.00163	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—KRAS—rectum cancer	0.000856	0.00161	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—KRAS—rectum cancer	0.00085	0.0016	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—NRAS—rectum cancer	0.000845	0.00159	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—NRAS—rectum cancer	0.000809	0.00152	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—NRAS—rectum cancer	0.000809	0.00152	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—KRAS—rectum cancer	0.000801	0.0015	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.0008	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—NRAS—rectum cancer	0.000796	0.00149	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—HRAS—rectum cancer	0.000783	0.00147	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—HRAS—rectum cancer	0.000771	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—HRAS—rectum cancer	0.000765	0.00144	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—NRAS—rectum cancer	0.000761	0.00143	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—NRAS—rectum cancer	0.00076	0.00143	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—NRAS—rectum cancer	0.000756	0.00142	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—NRAS—rectum cancer	0.000753	0.00141	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—NRAS—rectum cancer	0.000749	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—rectum cancer	0.000746	0.0014	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—rectum cancer	0.000741	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—TYMS—rectum cancer	0.00074	0.00139	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—NRAS—rectum cancer	0.000735	0.00138	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—HRAS—rectum cancer	0.000728	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—KRAS—rectum cancer	0.000727	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—HRAS—rectum cancer	0.000723	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.000705	0.00132	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—NRAS—rectum cancer	0.000705	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—NRAS—rectum cancer	0.000705	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—NRAS—rectum cancer	0.000698	0.00131	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.000697	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—KRAS—rectum cancer	0.000696	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—KRAS—rectum cancer	0.000696	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—NRAS—rectum cancer	0.000692	0.0013	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—NRAS—rectum cancer	0.000689	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—KRAS—rectum cancer	0.000685	0.00129	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—HRAS—rectum cancer	0.000681	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TYMS—rectum cancer	0.000662	0.00124	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—KRAS—rectum cancer	0.000655	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—KRAS—rectum cancer	0.000654	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—KRAS—rectum cancer	0.000651	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—KRAS—rectum cancer	0.000648	0.00122	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—KRAS—rectum cancer	0.000645	0.00121	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—KRAS—rectum cancer	0.000632	0.00119	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	0.000624	0.00117	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—HRAS—rectum cancer	0.000618	0.00116	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—NRAS—rectum cancer	0.000608	0.00114	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—HRAS—rectum cancer	0.000608	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—KRAS—rectum cancer	0.000606	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.000606	0.00114	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—KRAS—rectum cancer	0.000606	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	0.000603	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—KRAS—rectum cancer	0.000601	0.00113	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.0006	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—KRAS—rectum cancer	0.000596	0.00112	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—KRAS—rectum cancer	0.000593	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—HRAS—rectum cancer	0.000592	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—HRAS—rectum cancer	0.000582	0.00109	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—rectum cancer	0.000571	0.00107	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000571	0.00107	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—rectum cancer	0.000562	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—HRAS—rectum cancer	0.000559	0.00105	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TYMS—rectum cancer	0.000557	0.00105	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—HRAS—rectum cancer	0.000557	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—HRAS—rectum cancer	0.000556	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—HRAS—rectum cancer	0.000553	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—HRAS—rectum cancer	0.000551	0.00103	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—HRAS—rectum cancer	0.000548	0.00103	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	0.000537	0.00101	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—KRAS—rectum cancer	0.000523	0.000983	CbGpPWpGaD
Sulindac—ALB—Hemostasis—ITGA2—rectum cancer	0.000521	0.000978	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	0.000519	0.000975	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—rectum cancer	0.000518	0.000973	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000515	0.000968	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—HRAS—rectum cancer	0.000515	0.000968	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—HRAS—rectum cancer	0.000515	0.000968	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—HRAS—rectum cancer	0.000511	0.000959	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00051	0.000957	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000507	0.000952	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—HRAS—rectum cancer	0.000506	0.000951	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—HRAS—rectum cancer	0.000504	0.000947	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.000488	0.000917	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—NRAS—rectum cancer	0.00048	0.000901	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	0.000457	0.000857	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HRAS—rectum cancer	0.000445	0.000835	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—rectum cancer	0.000443	0.000833	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	0.000441	0.000829	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—NRAS—rectum cancer	0.000434	0.000816	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.00042	0.000789	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—KRAS—rectum cancer	0.000413	0.000776	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—rectum cancer	0.000391	0.000735	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—KRAS—rectum cancer	0.000374	0.000702	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NRAS—rectum cancer	0.000359	0.000675	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.000357	0.000671	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—HRAS—rectum cancer	0.000351	0.000659	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000339	0.000637	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—HRAS—rectum cancer	0.000318	0.000597	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NRAS—rectum cancer	0.00031	0.000582	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KRAS—rectum cancer	0.000309	0.000581	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NRAS—rectum cancer	0.000304	0.000571	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000302	0.000566	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—rectum cancer	0.000275	0.000516	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NRAS—rectum cancer	0.000274	0.000514	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—KRAS—rectum cancer	0.000267	0.000501	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HRAS—rectum cancer	0.000263	0.000494	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—KRAS—rectum cancer	0.000262	0.000491	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KRAS—rectum cancer	0.000236	0.000442	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—rectum cancer	0.000233	0.000437	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HRAS—rectum cancer	0.000227	0.000426	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HRAS—rectum cancer	0.000222	0.000418	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—rectum cancer	0.00022	0.000412	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TYMS—rectum cancer	0.000213	0.0004	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HRAS—rectum cancer	0.0002	0.000376	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—NRAS—rectum cancer	0.000175	0.000328	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TYMS—rectum cancer	0.000169	0.000318	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NRAS—rectum cancer	0.000159	0.000299	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—KRAS—rectum cancer	0.00015	0.000282	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TYMS—rectum cancer	0.00015	0.000282	CbGpPWpGaD
Sulindac—MAPK3—Disease—NRAS—rectum cancer	0.000147	0.000276	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NRAS—rectum cancer	0.000146	0.000275	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KRAS—rectum cancer	0.000137	0.000258	CbGpPWpGaD
Sulindac—ALB—Metabolism—TYMS—rectum cancer	0.000137	0.000257	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HRAS—rectum cancer	0.000128	0.00024	CbGpPWpGaD
Sulindac—MAPK3—Disease—KRAS—rectum cancer	0.000127	0.000238	CbGpPWpGaD
Sulindac—ALB—Hemostasis—KRAS—rectum cancer	0.000126	0.000236	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HRAS—rectum cancer	0.000117	0.000219	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—rectum cancer	0.000112	0.00021	CbGpPWpGaD
Sulindac—MAPK3—Disease—HRAS—rectum cancer	0.000108	0.000202	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HRAS—rectum cancer	0.000107	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NRAS—rectum cancer	0.000103	0.000194	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TYMS—rectum cancer	9.57e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KRAS—rectum cancer	8.87e-05	0.000167	CbGpPWpGaD
Sulindac—PTGS2—Disease—NRAS—rectum cancer	8.76e-05	0.000164	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—rectum cancer	7.89e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HRAS—rectum cancer	7.54e-05	0.000142	CbGpPWpGaD
Sulindac—PTGS2—Disease—KRAS—rectum cancer	7.54e-05	0.000142	CbGpPWpGaD
Sulindac—PTGS2—Disease—HRAS—rectum cancer	6.41e-05	0.00012	CbGpPWpGaD
